Calidi Biotherapeutics Inc. (CLDI) News CLDI Home News Ratings Charts Calidi Biotherapeutics Inc. (CLDI): $1.35 0.17 (+14.42%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum D Stability D Sentiment Get Rating Quality D Add CLDI to Watchlist Sign Up Industry: Medical - Pharmaceuticals Industry D Ranked #160 of 161 in industry See All 'A' Rated Buy Stocks Filter CLDI News Items All News Types Featured Stories AcquisitionAirlineAutomobilesBarron'sBiotechnologyBuffettBusiness/Consumer ServicesBuybackCommentaryCommoditiesConsumer GoodsCorp. NewsCramerDebt OfferingDefenseDividendDow Jones Industrial AverageDowngradeEarningsEconomic DataEnergyETFsFAANGFederal ReserveFinancialFood & BeverageGuidance DownGuidance UpHealthcareHedge FundHomebuildersInsider BuyingInsider SellingIPOsJob CutsLeisure/Arts/HospitalityM&AMarijuanaMediaMetals & MiningMgmt ChangeNew Coverage (Bearish)New Coverage (Bullish)New Coverage (Neutral)OptionsPE InvestmentProduct NewsPT LoweredPT RaisedPT Set (Bearish)PT Set (Bullish)PT Set (Neutral)Rating Reiterated (Bearish)Rating Reiterated (Bullish)Rating Reiterated (Neutral)Real EstateRestaurantsResumes Coverage (Bearish)Resumes Coverage (Bullish)Resumes Coverage (Neutral)RetailRumorSemiconductorSocial MediaSpin-offStock OfferingStock SplitTechnologyTelecomTransportation LogisticsTrumpUpgradeUtilities Search CLDI News Results Date Symbol Company Title Start End Change POWR Rating Loading, please wait... Load More News Items Most Popular Stories View All • 2 Concerns for Investors in October • 3 Cybersecurity Stocks Defending Against Digital Threats • 3 Oil Stocks With High Upside as Global Demand Rebounds • 3 Tech Stocks Under $10 That Could Deliver Big Gains • Investors…Why Be Bearish? View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
